tradingkey.logo
๎™

MiMedx Group Inc

MDXG

7.150USD

+0.210+3.03%
์ข…๊ฐ€ย 09/18, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
1.06B์‹œ๊ฐ€์ด์•ก
32.87P/E TTM
๎™

MiMedx Group Inc

7.150

+0.210+3.03%

TradingKey ์ฃผ์‹ ์ ์ˆ˜

๊ฑด๊ฐ•

๋ฐธ๋ฅ˜์—์ด์…˜

์˜ˆ์ƒ

๋ชจ๋ฉ˜ํ…€

๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„

์œ„ํ—˜ ์š”์†Œ

์œ ์‚ฌ ์ข…๋ชฉ

TradingKey ์ฃผ์‹ ์ ์ˆ˜

๊ฑด๊ฐ•

๋ฐธ๋ฅ˜์—์ด์…˜

์˜ˆ์ƒ

๋ชจ๋ฉ˜ํ…€

๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„

์œ„ํ—˜ ์š”์†Œ

์œ ์‚ฌ ์ข…๋ชฉ

TradingKey ์ฃผ์‹ ์ ์ˆ˜

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

์ฃผ์š” ์ธ์‚ฌ์ดํŠธ

ํšŒ์‚ฌ์˜ ํŽ€๋”๋ฉ˜ํ„ธ์€ ๋น„๊ต์  ์•„์ฃผ ๊ฑด์ „ํ•œํ•œ ํŽธ์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ๋ฐธ๋ฅ˜์—์ด์…˜์€ ์ ์ •ํ•˜๊ฒŒ ํ‰๊ฐ€๋œ์œผ๋กœ ๊ฐ„์ฃผ๋ฉ๋‹ˆ๋‹ค. ๊ธฐ๊ด€์˜ ์ธ์ง€๋„๋Š” ๋งค์šฐ ๋†’์€์ž…๋‹ˆ๋‹ค. ์ง€๋‚œ 30์ผ ๋™์•ˆ ์—ฌ๋Ÿฌ ์• ๋„๋ฆฌ์ŠคํŠธ๋“ค์ด ์ด ํšŒ์‚ฌ๋ฅผ ๋งค์ˆ˜๋กœ ํ‰๊ฐ€ํ–ˆ์Šต๋‹ˆ๋‹ค. ํ‰๊ท ์ ์ธ ์ฃผ์‹์‹œ์žฅ ์„ฑ๊ณผ์—๋„ ๋ถˆ๊ตฌํ•˜๊ณ , ํšŒ์‚ฌ๋Š” ๊ฐ•ํ•œ ํŽ€๋”๋ฉ˜ํ„ธ๊ณผ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๋ฅผ ๋ณด์ด๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. ์ฃผ๊ฐ€๋Š” ์ง€์ง€์„ ๊ณผ ์ €ํ•ญ์„  ์‚ฌ์ด์—์„œ ํšก๋ณดํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ๋ฒ”์œ„ ๋งค๋งค ๊ธฐ๋ฐ˜์˜ ์Šค์œ™ ํŠธ๋ ˆ์ด๋”ฉ์— ์ ํ•ฉํ•œ ์ƒํ™ฉ์ž…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜๎˜ฐ๎˜ฐ

๊ด€๋ จ ์ •๋ณด

์‚ฐ์—… ์ˆœ์œ„
5 / 507
์ „์ฒด ์ˆœ์œ„
61 / 4723
์‚ฐ์—…
์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๋ฐ์ดํ„ฐ ์—†์Œ

๋ ˆ์ด๋” ์ฐจํŠธ

ํ˜„์žฌ ๊ฐ€๊ฒฉ
๊ณผ๊ฑฐ

๋ถ„์„๊ฐ€ ๋ชฉํ‘œ๊ฐ€

5 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
12.200
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+75.04%
์ƒ์Šน ์—ฌ๋ ฅ
๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

๊ธฐ์—… ํ•˜์ด๋ผ์ดํŠธ

๊ฐ•์ ์œ„ํ—˜ ์š”์†Œ
MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
๋†’์€ ์„ฑ์žฅ
ํšŒ์‚ฌ์˜ ๋งค์ถœ์€ ์ง€๋‚œ 3๋…„๊ฐ„ ๊พธ์ค€ํžˆ ์„ฑ์žฅํ•ด์™”์œผ๋ฉฐ, ์—ฐํ‰๊ท  30.26%์˜ ์ฆ๊ฐ€์œจ์„ ๊ธฐ๋กํ–ˆ์Šต๋‹ˆ๋‹ค.
๊ณผ๋Œ€ ํ‰๊ฐ€๋œ
ํšŒ์‚ฌ์˜ ์ตœ์‹  PE์€ 31.76๋กœ, ์ตœ๊ทผ 3๋…„ ๊ธฐ์ค€ ๋†’์€ ๋ฐฑ๋ถ„์œ„ ๋ฒ”์œ„์— ์†ํ•ฉ๋‹ˆ๋‹ค.
๊ธฐ๊ด€ ๋งค๋„
์ตœ์‹  ๊ธฐ๊ด€ ๋ณด์œ  ์ฃผ์‹ ์ˆ˜๋Š” 106.45M์ฃผ์ด๋ฉฐ, ์ „ ๋ถ„๊ธฐ ๋Œ€๋น„ 3.61% ๊ฐ์†Œํ–ˆ์Šต๋‹ˆ๋‹ค.
๋” ๋ฑ…๊ฐ€๋“œ๊ฐ€ ๋ณด์œ 
์Šคํƒ€ ํˆฌ์ž์ž ๋” ๋ฑ…๊ฐ€๋“œ์ด(๊ฐ€) ์ด ์ฃผ์‹ 6.93M์ฃผ๋ฅผ ๋ณด์œ ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์žฌ๋ฌด ๊ฑด์ „์„ฑ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ์žฌ๋ฌด ์ ์ˆ˜๋Š” 9.30์ด๋ฉฐ, ์ด๋Š” ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์—…๊ณ„ ํ‰๊ท ์ธ 6.93๋ณด๋‹ค ์ด์ƒ์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ์žฌ๋ฌด ์ƒํƒœ๋Š” ๊ฒฌ๊ณ ํ•œ์ž…๋‹ˆ๋‹ค. ๊ทธ๋ฆฌ๊ณ  ํšŒ์‚ฌ์˜ ์šด์˜ ํšจ์œจ์„ฑ์€ ์ƒ๋‹จ์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ์ตœ์‹  ๋ถ„๊ธฐ ๋งค์ถœ์€ 98.61M๋ฅผ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ์ด๋Š” ์ „๋…„ ๋Œ€๋น„ 13.07%์˜ ์ฆ๊ฐ€๋ฅผ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค. ํ•œํŽธ, ์ˆœ์ด์ต์€ ์ „๋…„ ๋Œ€๋น„ 45.43%์˜ ์ฆ๊ฐ€๋ฅผ ๋ณด์˜€์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
9.30
๋ณ€๊ฒฝ
0
๎™น

์žฌ๋ฌด ์ •๋ณด

๎˜ญ10.00

๊ด€๋ จ ์ง€ํ‘œ

ํ˜„๊ธˆ ๋ฐ ํ˜„๊ธˆ์„ฑ ์ž์‚ฐ

์ด ์ž์‚ฐ

๋ถ€์ฑ„ ์ด๊ณ„

์ž์œ  ํ˜„๊ธˆ ํ๋ฆ„

๋ฐ์ดํ„ฐ ์—†์Œ
๎™ธ

์ˆ˜์ต์˜ ์งˆ

๎˜ญ8.79
๎™ธ

์šด์˜ ํšจ์œจ์„ฑ

๎˜ญ10.00
๎™ธ

์„ฑ์žฅ ์ž ์žฌ๋ ฅ

๎˜ญ10.00
๎™ธ

์ฃผ์ฃผ ์ˆ˜์ต๋ฅ 

๎˜ญ7.69

ํšŒ์‚ฌ ๊ฐ€์น˜ ํ‰๊ฐ€๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ๋ฐธ๋ฅ˜์—์ด์…˜ ์ ์ˆ˜๋Š” 8.18์ด๋ฉฐ, ์ด๋Š” ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์—…๊ณ„ ํ‰๊ท ์ธ 3.06๋ณด๋‹ค ์ด์ƒ์ž…๋‹ˆ๋‹ค. ํ˜„์žฌ ์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ(P/E)์€ 31.76๋กœ, ์ตœ๊ทผ ๊ณ ์  19.71 ๋Œ€๋น„ -37.95% ๋‚ฎ๊ณ , ์ตœ๊ทผ ์ €์  -11.38 ๋Œ€๋น„ 135.83% ๋†’์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
7.38
๋ณ€๊ฒฝ
0.8

๋ฐธ๋ฅ˜์—์ด์…˜

์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ

P/B

์ฃผ๊ฐ€๋งค์ถœ๋น„์œจ

์ฃผ๊ฐ€ํ˜„๊ธˆํ๋ฆ„๋น„์œจ

์‚ฐ์—… ์ˆœ์œ„ 5/507
๋ฐ์ดํ„ฐ ์—†์Œ

์˜ˆ์ƒ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ์‹ค์  ์ „๋ง ์ ์ˆ˜๋Š” 8.00์ด๋ฉฐ, ์ด๋Š” ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์—…๊ณ„ ํ‰๊ท ์ธ 8.03๋ณด๋‹ค ๋ฏธ๋งŒ์ž…๋‹ˆ๋‹ค. MiMedx Group Inc์˜ ํ‰๊ท  ๋ชฉํ‘œ๊ฐ€๋Š” 12.00์ด๋ฉฐ, ์ตœ๊ณ ๊ฐ€๋Š” 13.00, ์ตœ์ €๊ฐ€๋Š” 12.00์ž…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
8.00
๋ณ€๊ฒฝ
0

๋ชฉํ‘œ๊ฐ€

๋ฐ์ดํ„ฐ ์—†์Œ

์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€

5 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
๋งค์ˆ˜
ํ˜„์žฌ ๋“ฑ๊ธ‰
12.200
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
+75.79%
์ƒ์Šน ์—ฌ๋ ฅ
๊ฐ•๋ ฅ ๋งค์ˆ˜
๋งค์ˆ˜
์œ ์ง€
๋งค๋„
๊ฐ•๋ ฅ ๋งค๋„

๋™์ข…์—…๊ณ„ ๋น„๊ต

554
์ด๊ณ„
5
์ค‘๊ฐ„
6
ํ‰๊ท 
ํšŒ์‚ฌ ์ด๋ฆ„
ํ‰๊ฐ€
๋ถ„์„๊ฐ€
MiMedx Group Inc
MDXG
5
CRISPR Therapeutics AG
CRSP
30
Intellia Therapeutics Inc
NTLA
26
Exact Sciences Corp
EXAS
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

์žฌ๋ฌด ์˜ˆ์ธก

EPS

์ˆ˜์ต

์ˆœ์ด์ต

EBIT

๋ฐ์ดํ„ฐ ์—†์Œ

๋ฉด์ฑ… ์กฐํ•ญ: ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€ ๋ฐ ๋ชฉํ‘œ ์ฃผ๊ฐ€๋Š” ์ •๋ณด ์ œ๊ณต์„ ์œ„ํ•œ ๋ชฉ์ ์œผ๋กœ LSEG์—์„œ ์ œ๊ณต๋˜๋ฉฐ, ํˆฌ์ž ์กฐ์–ธ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

๋ชจ๋ฉ˜ํ…€๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

์ด ํšŒ์‚ฌ์˜ ํ˜„์žฌ ์ฃผ๊ฐ€ ๋ชจ๋ฉ˜ํ…€ ์ ์ˆ˜๋Š” 6.38์ด๋ฉฐ, ์ด๋Š” ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์—…์ข… ํ‰๊ท  6.32๋ณด๋‹ค ์ด์ƒ์ž…๋‹ˆ๋‹ค. ํšก๋ณด: ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 7.28 ์ €ํ•ญ์„ ๊ณผ 6.70 ์ง€์ง€์„  ์‚ฌ์ด์—์„œ ๊ฑฐ๋ž˜๋˜๊ณ  ์žˆ์–ด, ๊ตฌ๊ฐ„ ๋งค๋งค(Swing Trading)์— ์ ํ•ฉํ•œ ํ๋ฆ„์„ ๋ณด์ด๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
6.61
๋ณ€๊ฒฝ
-0.23

์ €ํ•ญ์„  & ์ง€์ง€์„ 

๋ฐ์ดํ„ฐ ์—†์Œ

์ง€ํ‘œ

๎˜ฐ
๎˜ฐ

์ง€ํ‘œ ๊ธฐ๋Šฅ์€ ๋‹ค์–‘ํ•œ ๊ธฐ๋ฒ• ์ง€ํ‘œ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ ์—ฌ๋Ÿฌ ์ข…๋ชฉ์— ๋Œ€ํ•œ ๊ฐ€์น˜์™€ ๋ฐฉํ–ฅ ๋ถ„์„์„ ์ œ๊ณตํ•˜๋ฉฐ, ๊ธฐ์ˆ ์  ์š”์•ฝ๋„ ํ•จ๊ป˜ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

์ด ๊ธฐ๋Šฅ์—๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์‚ฌ์šฉ๋˜๋Š” 9๊ฐ€์ง€ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๊ฐ€ ํฌํ•จ๋ฉ๋‹ˆ๋‹ค: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX, MA. ๋˜ํ•œ ํ•„์š”์— ๋”ฐ๋ผ ์‹œ๊ฐ„ ํ”„๋ ˆ์ž„์„ ์กฐ์ •ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ธฐ์ˆ  ๋ถ„์„์€ ํˆฌ์ž ์ฐธ์กฐ์˜ ์ผ๋ถ€์ผ ๋ฟ์ด๋ฉฐ, ๋ฐฉํ–ฅ์„ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด ์ˆซ์ž ๊ฐ’์„ ์‚ฌ์šฉํ•˜๋Š” ๋ฐ์—๋Š” ์ ˆ๋Œ€์ ์ธ ๊ธฐ์ค€์ด ์—†์Šต๋‹ˆ๋‹ค. ๊ฒฐ๊ณผ๋Š” ์ฐธ์กฐ์šฉ์ผ ๋ฟ์ด๋ฉฐ, ์ง€ํ‘œ ๊ณ„์‚ฐ ๋ฐ ์š”์•ฝ์˜ ์ •ํ™•์„ฑ์— ๋Œ€ํ•ด์„œ๋Š” ์ฑ…์ž„์ง€์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

์ง€ํ‘œ
๋งค๋„(1)
์ค‘๋ฆฝ(3)
๋งค์ˆ˜(3)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MACD(12,26,9)
-0.041
์ค‘๋ฆฝ
RSI(14)
53.779
์ค‘๋ฆฝ
STOCH(KDJ)(9,3,3)
55.498
๋งค์ˆ˜
ATR(14)
0.194
๊ณ ๋ณ€๋™์„ฑ
CCI(14)
36.487
์ค‘๋ฆฝ
Williams %R
22.727
๋งค์ˆ˜
TRIX(12,20)
-0.029
๋งค๋„
StochRSI(14)
100.000
๋งค์ˆ˜
์ด๋™ ํ‰๊ท 
๋งค๋„(1)
์ค‘๋ฆฝ(0)
๋งค์ˆ˜(5)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MA5
6.994
๋งค์ˆ˜
MA10
7.043
๋งค์ˆ˜
MA20
7.092
๋งค์ˆ˜
MA50
6.988
๋งค์ˆ˜
MA100
6.760
๋งค์ˆ˜
MA200
7.546
๋งค๋„

๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ๊ธฐ๊ด€ ์ธ์ง€๋„ ์ ์ˆ˜๋Š” 7.00์ด๋ฉฐ, ์ด๋Š” ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์—…๊ณ„ ํ‰๊ท ์ธ 5.96๋ณด๋‹ค ์ด์ƒ ์ˆ˜์ค€์ž…๋‹ˆ๋‹ค. ์ตœ์‹  ๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ  ๋น„์œจ์€ 71.95%์ด๋ฉฐ, ์ด๋Š” ๋ถ„๊ธฐ ๋Œ€๋น„ ๊ฐ์†Œ 0.62%์ž…๋‹ˆ๋‹ค. ์ตœ๋Œ€ ๊ธฐ๊ด€ ์ฃผ์ฃผ๋Š” ๋” ๋ฑ…๊ฐ€๋“œ๋กœ, ์ด 6.93M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ ์ด๋Š” ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 4.69%์— ํ•ด๋‹นํ•ฉ๋‹ˆ๋‹ค. ๋ณด์œ  ์ง€๋ถ„์€ 3.05% ์ฆ๊ฐ€๋ฅผ ๊ธฐ๋กํ–ˆ์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
7.00
๋ณ€๊ฒฝ
0

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์ฃผ ํ™œ๋™

์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
Chg %
EW Healthcare Partners
28.20M
--
BlackRock Institutional Trust Company, N.A.
8.58M
+2.14%
Trigran Investments, Inc.
7.60M
-0.29%
The Vanguard Group, Inc.
Star Investors๎˜ฏ
6.69M
+0.08%
Paradigm Capital Management, Inc.
4.68M
-0.06%
State Street Global Advisors (US)
3.46M
+5.79%
Geode Capital Management, L.L.C.
2.91M
+4.79%
Dimensional Fund Advisors, L.P.
2.01M
+11.47%
Renaissance Technologies LLC
Star Investors๎˜ฏ
1.93M
+6.97%
Cannell Capital, LLC
2.13M
-41.39%
1
2

์œ„ํ—˜ ์š”์†Œ๎˜ฐ๎˜ฐ

ํ†ตํ™”: USD ๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ๏ผš2025-09-17

ํšŒ์‚ฌ์˜ ํ˜„์žฌ ๋ฆฌ์Šคํฌ ํ‰๊ฐ€ ์ ์ˆ˜๋Š” 4.21์ด๋ฉฐ, ์ด๋Š” ์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ ์‚ฐ์—… ํ‰๊ท ์ธ 3.33๋ณด๋‹ค ์ด์ƒ ์ˆ˜์ค€์ž…๋‹ˆ๋‹ค. ํšŒ์‚ฌ์˜ ๋ฒ ํƒ€ ๊ฐ’์€ 1.74์ž…๋‹ˆ๋‹ค. ์ด๋Š” ํ•ด๋‹น ์ฃผ์‹์ด ์ƒ์Šน์žฅ์—์„œ๋Š” ์ง€์ˆ˜๋ฅผ ์ดˆ๊ณผํ•˜์—ฌ ์„ฑ๊ณผ๋ฅผ ๋‚ด๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์ง€๋งŒ, ํ•˜๋ฝ์žฅ์—์„œ๋Š” ์ง€์ˆ˜๋ณด๋‹ค ๋” ํฐ ํ•˜๋ฝ์„ ๊ฒช๋Š” ๊ฒฝํ–ฅ์ด ์žˆ์Œ์„ ๋‚˜ํƒ€๋ƒ…๋‹ˆ๋‹ค.

์ฃผ์‹ ์ ์ˆ˜

๊ด€๋ จ ์ •๋ณด

๊ณผ๊ฑฐ
4.21
๋ณ€๊ฒฝ
0
S&P 500 ์ง€์ˆ˜ ๋Œ€๋น„ ๋ฒ ํƒ€๊ฐ’
1.74
VaR
+5.18%
240์ผ ์ตœ๋Œ€ ๋‚™ํญ
+40.41%
240์ผ ๋ณ€๋™์„ฑ
+49.91%
๋Œ์•„๊ฐ€๊ธฐ
์ตœ๊ณ  ์ผ๊ฐ„ ์ˆ˜์ต๋ฅ 
60์ผ
+10.28%
120์ผ
+10.28%
5๋…„
+39.37%
์ตœ์ € ์ผ๊ฐ„ ์ˆ˜์ต๋ฅ 
60์ผ
-6.91%
120์ผ
-8.14%
5๋…„
-59.56%
์ƒคํ”„ ๋น„์œจ
60์ผ
+1.91
120์ผ
-0.41
5๋…„
+0.38
์œ„ํ—˜ ์š”์†Œ
์ตœ๋Œ€ ๋‚™ํญ
240์ผ
+40.41%
3๋…„
+40.41%
5๋…„
+83.39%
์ˆ˜์ต ๋Œ€๋น„ ๋‚™ํญ ๋น„์œจ
240์ผ
+0.44
3๋…„
+1.07
5๋…„
+0.03
์™œ๋„
240์ผ
+3.22
3๋…„
+2.96
5๋…„
-1.17
๋ณ€๋™์„ฑ
์‹คํ˜„ ๋ณ€๋™์„ฑ
240์ผ
+49.91%
5๋…„
+72.19%
ํ‘œ์ค€ํ™”๋œ ์ง„ํญ ๋ฒ”์œ„
240์ผ
+4.18%
5๋…„
+5.16%
ํ•˜๋ฐฉ ๋ฆฌ์Šคํฌ ์กฐ์ • ์ˆ˜์ต๋ฅ 
120์ผ
-67.75%
240์ผ
-67.75%
์ตœ๊ณ  ์ผ๊ฐ„ ์ƒ์Šน ๋ณ€๋™์„ฑ
60์ผ
+51.07%
์ตœ๊ณ  ์ผ๊ฐ„ ํ•˜๋ฝ ๋ณ€๋™์„ฑ
60์ผ
+36.67%
์œ ๋™์„ฑ
ํ‰๊ท  ํšŒ์ „์œจ
60์ผ
+0.51%
120์ผ
+0.48%
5๋…„
--
ํšŒ์ „์œจ ํŽธ์ฐจ
20์ผ
-17.06%
60์ผ
+2.75%
120์ผ
-3.41%

์œ ์‚ฌ ์ข…๋ชฉ
๎˜ฐ๎˜ฐ

์ƒ๋ช…๊ณตํ•™ ๋ฐ ์˜๋ฃŒ ์—ฐ๊ตฌ
๎™
MiMedx Group Inc
MiMedx Group Inc
MDXG
7.55 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Krystal Biotech Inc
Krystal Biotech Inc
KRYS
8.13 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Alkermes Plc
Alkermes Plc
ALKS
7.85 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc
ACAD
7.65 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Zymeworks Inc
Zymeworks Inc
ZYME
7.61 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
Stoke Therapeutics Inc
Stoke Therapeutics Inc
STOK
7.55 /10
์ฃผ์‹ ์ ์ˆ˜
์žฌ๋ฌด ๊ฑด์ „์„ฑ
๋ฐธ๋ฅ˜์—์ด์…˜
์˜ˆ์ƒ
๋ชจ๋ฉ˜ํ…€
๊ธฐ๊ด€ ํˆฌ์ž์ž ์ธ์ง€๋„
์œ„ํ—˜ ์š”์†Œ
๋” ๋ณด๊ธฐ
tradingkey.logo
๋‹น์ผ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” Refinitiv์—์„œ ์ œ๊ณตํ•˜๋ฉฐ, ์ด์šฉ ์•ฝ๊ด€์ด ์ ์šฉ๋ฉ๋‹ˆ๋‹ค. ์—ญ์‚ฌ์  ๋ฐ ํ˜„์žฌ ์ข…๊ฐ€ ๋ฐ์ดํ„ฐ๋Š” Refinitiv์—์„œ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๋ชจ๋“  ์‹œ์„ธ๋Š” ํ˜„์ง€ ๊ฑฐ๋ž˜์†Œ ์‹œ๊ฐ„ ๊ธฐ์ค€์ž…๋‹ˆ๋‹ค. ๋ฏธ๊ตญ ์ฃผ์‹ ์‹œ์„ธ์˜ ์‹ค์‹œ๊ฐ„ ๋งˆ์ง€๋ง‰ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” Nasdaq์„ ํ†ตํ•ด ๋ณด๊ณ ๋œ ๊ฑฐ๋ž˜๋งŒ ๋ฐ˜์˜๋ฉ๋‹ˆ๋‹ค. ๋‹น์ผ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” ์ตœ์†Œ 15๋ถ„ ์ง€์—ฐ๋˜๊ฑฐ๋‚˜ ๊ฑฐ๋ž˜์†Œ ์š”๊ตฌ ์‚ฌํ•ญ์— ๋”ฐ๋ผ ๋‹ค๋ฅผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
* ์ฐธ๊ณ ์ž๋ฃŒ, ๋ถ„์„ ๋ฐ ํŠธ๋ ˆ์ด๋”ฉ ์ „๋žต์€ ์ œ3์ž ์ œ๊ณต์—…์ฒด์ธ Trading Central์—์„œ ์ œ๊ณตํ•˜๋ฉฐ, ๋ถ„์„๊ฐ€์˜ ๋…๋ฆฝ์ ์ธ ํ‰๊ฐ€์™€ ํŒ๋‹จ์— ๊ธฐ๋ฐ˜ํ•œ ์‹œ๊ฐ์œผ๋กœ, ํˆฌ์ž์ž์˜ ํˆฌ์ž ๋ชฉํ‘œ์™€ ์žฌ์ • ์ƒํ™ฉ์€ ๊ณ ๋ ค๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
KeyAI
๎™